IRIS
CALABRESI, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 53.679
EU - Europa 2.829
AS - Asia 1.409
Continente sconosciuto - Info sul continente non disponibili 20
SA - Sud America 14
OC - Oceania 5
AF - Africa 3
Totale 57.959
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 53.667
UA - Ucraina 831
SG - Singapore 692
DE - Germania 509
CN - Cina 492
IE - Irlanda 465
SE - Svezia 227
FR - Francia 172
IT - Italia 165
FI - Finlandia 159
KR - Corea 158
GB - Regno Unito 128
RU - Federazione Russa 89
PL - Polonia 48
JP - Giappone 26
EU - Europa 19
KG - Kirghizistan 12
NL - Olanda 11
IN - India 8
CA - Canada 7
CL - Cile 7
CZ - Repubblica Ceca 7
BR - Brasile 5
AU - Australia 4
DM - Dominica 4
IR - Iran 4
BE - Belgio 3
DK - Danimarca 3
NG - Nigeria 3
UZ - Uzbekistan 3
AR - Argentina 2
CH - Svizzera 2
KZ - Kazakistan 2
LT - Lituania 2
NP - Nepal 2
PT - Portogallo 2
RO - Romania 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
GR - Grecia 1
HK - Hong Kong 1
KH - Cambogia 1
KW - Kuwait 1
LK - Sri Lanka 1
MF - Saint Martin 1
MT - Malta 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TR - Turchia 1
Totale 57.959
Salva come PNG Salva come JPEG
Città #
Woodbridge 17.722
Wilmington 14.503
Houston 12.876
Fairfield 1.675
Ann Arbor 1.322
Jacksonville 774
Ashburn 650
Seattle 627
Singapore 617
Cambridge 574
Dublin 465
Chandler 408
Medford 327
Beijing 198
Santa Clara 184
Lawrence 160
Zhengzhou 117
New York 114
Mülheim 112
Menlo Park 102
Dearborn 82
San Diego 56
Kraków 46
University Park 39
Rome 37
San Mateo 37
Milan 33
Mcallen 32
Hefei 29
Mountain View 29
Falls Church 26
Shanghai 25
Verona 25
Saint Petersburg 24
Nanjing 21
Redwood City 19
Detroit 18
Guangzhou 18
Moscow 18
Palo Alto 18
Norwalk 17
London 15
Monmouth Junction 12
Redmond 12
Nanchang 10
Indiana 9
Kunming 9
Brno 7
Hangzhou 7
Jinan 6
Munich 6
San Francisco 6
Florence 5
Groningen 5
Prescot 5
Boardman 4
Chicago 4
Fuzhou 4
Kilburn 4
New Bedfont 4
Nuremberg 4
Roseau 4
Simi Valley 4
São Paulo 4
Tokyo 4
Toronto 4
Wandsworth 4
Brussels 3
Changsha 3
Chengdu 3
Hounslow 3
Mantova 3
Perugia 3
Riccione 3
Shenyang 3
Augusta 2
Bari 2
Bengaluru 2
Birmingham 2
Bonn 2
Chiyoda-ku 2
Creede 2
Frederiksberg 2
Hanoi 2
Hebei 2
Kathmandu 2
La Spezia 2
Lausanne 2
Liverpool 2
Locorotondo 2
Muenster 2
Naples 2
Napoli 2
Pizzo 2
Shaoxing 2
Acton 1
Almaty 1
Athens 1
Atlanta 1
Auburn Hills 1
Totale 54.407
Salva come PNG Salva come JPEG
Nome #
Early synaptic dysfunction in Parkinson's disease: Insights from animal models 453
Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism 446
Evidence of hydrogen sulfide involvement in amyotrophic lateral sclerosis 445
A synaptic mechanism underlying the behavioral abnormalities induced by manganese intoxication 443
Muscarinic IPSPs in rat striatal cholinergic interneurones 441
Actions of glycine on non-dopaminergic neurons of the rat substantia nigra 435
Hypoglycemia, hypoxia, and ischemia in a corticostriatal slice preparation: electrophysiologic changes and ascorbyl radical formation 434
Abnormal striatal GABA transmission in the mouse model for the fragile X syndrome 428
Neuronal vulnerability following inhibition of mitochondrial complex II: a possibile ionic mechanism for Huntington’s disease. 424
Neurophysiology of Parkinson's disease: from basic research to clinical correlates 424
The Project for a Scientific Psychology (1895): a Freudian anticipation of LTP-memory connection theory 422
Activation of dopamine D1-like receptors excites LTS interneurons of the striatum 421
Synaptic transmission in the striatum: from plasticity to neurodegeneration 421
Activation of group III metabotropic glutamate receptors depresses glutamatergic transmission at corticostriatal synapse 418
Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice 417
Striatal synaptic plasticity: implications for motor learning and Parkinson's disease 415
Metabotropic glutamate receptors and striatal synaptic plasticity: implications for neurological diseases 412
Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine 407
Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia 403
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 403
Unilateral dopamine denervation blocks corticostriatal LTP 401
Early ionic and membrane potential changes caused by the pesticide rotenone in striatal cholinergic interneurons 401
Synaptic plasticity in the ischaemic brain 400
Electrophysiological recordings and calcium measurements in striatal large aspiny interneurons in response to combined O2/glucose deprivation 400
Experimental parkinsonism modulates multiple genes involved in the transduction of dopaminergic signals in the striatum 400
Striatal spiny neurons and cholinergic interneurons express differential ionotropic glutamatergic responses and vulnerability: implications for ischemia and Huntington's disease 400
Role of Ca2+ in striatal LTD and LTP 400
Dopamine, acetylcholine and nitric oxide systems interact to induce corticostriatal synaptic plasticity 399
NR2B-containing NMDA receptors promote the neurotoxic effects of 3-nitropropionic acid but not of rotenone in the striatum 399
Removing pathogenic memories: a neurobiology of psychotherapy 398
Opposite membrane potential changes induced by glucose deprivation in striatal spiny neurons and in large aspiny interneurons 398
Lamotrigine and remacemide protect striatal neurons against in vitro ischemia: an electrophysiological study 396
Therapeutic doses of L-dopa reverse hypersensitivity of corticostriatal D2-dopamine receptors and glutamatergic overactivity in experimental parkinsonism 396
A critical role of the nitric oxide/cGMP pathway in corticostriatal long-term depression 395
Endogenous ACh enhances striatal NMDA-responses via M1-like muscarinic receptors and PKC activation 395
Behavioural learning-induced increase in spontaneous GABAA-dependent synaptic activity in rat striatal cholinergic interneurons 395
Long-term synaptic depression in the striatum: physiological and pharmacological characterization 395
Hyperkinetic disorders and loss of synaptic downscaling 395
Electrophysiology of dopamine D-1 receptors in the basal ganglia: old facts and new perspectives 394
Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine 393
L-DOPA treatment of parkinsonian rats changes the expression of Src, Lyn and PKC kinases 393
Endogenous dopamine amplifies ischemic long-term potentiation via D1 receptors 393
Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons 393
Receptor subtypes involved in the presynaptic and postsynaptic actions of dopamine on striatal interneurons 392
Ionic mechanisms underlying differential vulnerability to ischemia in striatal neurons 392
Transmitter release associated with long-term synaptic depression in rat corticostriatal slices 392
Deficits of glutamate transmission in the striatum of experimental hemiballism 391
Dopaminergic control of synaptic plasticity in the dorsal striatum 391
Cocaine and amphetamine depress striatal GABAergic synaptic transmission through D2 dopamine receptors 391
Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine 391
A field potential analysis on the effects of lamotrigine, GP 47779, and felbamate in neocortical slices 391
Metabotropic glutamate 2 receptors modulate synaptic inputs and calcium signals in striatal cholinergic interneurons 390
Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors 389
Activation of M1-like muscarinic receptors is required for the induction of corticostriatal LTP 389
Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents 389
SYNAPTIC PLASTICITY IN THE STRIATUM - ROLE OF GLUTAMATE AND DOPAMINE-RECEPTORS 388
Post-ischaemic long-term synaptic potentiation in the striatum: a putative mechanism for cell type-specific vulnerability 387
Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity 387
NF-kB/NOS cross-talk induced by mitochondrial complex II inhibition: implications for Huntington's disease 387
Blockade of M2-like muscarinic receptors enhances long-term potentiation at corticostriatal synapses 386
Inhibition of mitochondrial complex II alters striatal expression of genes involved in glutamatergic and dopaminergic signaling: possible implications for Huntington's disease 386
Engagement of rat striatal neurons by cortical epileptiform activity investigated with paired recordings 386
Permissive role of interneurons in corticostriatal synaptic plasticity 384
Striatal metabotropic glutamate receptor function following experimental parkinsonism and chronic levodopa treatment 383
Targeting striatal cholinergic interneurons in Parkinson's disease: focus on metabotropic glutamate receptors 382
The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia 382
Acetyl-L-carnitine protects striatal neurons against in vitro ischemia: the role of endogenous acetylcholine 382
Deficits of glutamate transmission in the striatum of toxic and genetic models of Huntington's disease 380
Tissue plasminogen activator is required for corticostriatal long-term potentiation 380
An in vitro electrophysiological study on the effects of phenytoin, lamotrigine and gabapentin on striatal neurons 378
Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission 378
Activation of metabotropic glutamate receptors inhibits calcium currents and GABA-mediated synaptic potentials in striatal neurons 378
Enhanced sensitivity of DJ-1-deficient dopaminergic neurons to energy metabolism impairment: role of Na+/K+ ATPase 377
Chronic cocaine prevents depotentiation at corticostriatal synapses 375
Interaction of A2A adenosine and D2 dopamine receptors modulates corticostriatal glutamatergic transmission 374
NR2B subunit exerts a critical role in postischemic synaptic plasticity 374
Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity 374
Long-term Potentiation in the Striatum is Unmasked by Removing the Voltage-dependent Magnesium Block of NMDA Receptor Channels 374
Long-term potentiation and memory processes in the psychological works of Sigmund Freud and in the formation of neuropsychiatric symptoms 373
The modulation of dopamine receptors in rat striatum 373
Basic research in substantia nigra and ventral tegmental area: clinical implications 373
Glutamate-triggered events inducing corticostriatal long-term depression 372
Pathological synaptic plasticity in the striatum: implications for Parkinson's disease 369
The modulation of calcium currents by the activation of mGluRs. Functional implications 369
A critical interaction between dopamine D2 receptors and endocannabinoids mediates the effects of cocaine on striatal gabaergic Transmission 368
Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors 367
Differential contribution of dopamine D2S and D2L receptors in the modulation of glutamate and GABA transmission in the striatum 367
Electrophysiology of sipatrigine: a lamotrigine derivative exhibiting neuroprotective effects 365
Synaptic plasticity during recovery from permanent occlusion of the middle cerebral artery 364
Electrophysiology of the neuroprotective agent riluzole on striatal spiny neurons 363
Ionotropic glutamate receptors: still a target for neuroprotection in brain ischemia? Insights from in vitro studies 361
Levodopa treatment reverses endocannabinoid system abnormalities in experimental parkinsonism 358
Receptor and post-receptor mechanisms of ischemic long-term potentiation in the striatum 356
Activation of beta1-adrenoceptors excites striatal cholinergic interneurons through a cAMP-dependent, protein kinase-independent pathway 356
Stimulation of nitric oxide-cGMP pathway excites striatal cholinergic interneurons via protein kinase G activation 356
Corticostriatal LTP requires combined mGluR1 and mGluR5 activation 356
Selective involvement of mGlu1 receptors in corticostriatal LTD 355
Functional coexpression of excitatory mGluR1 and mGluR5 on striatal cholinergic interneurons 355
Metabotropic glutamate receptor 5 mediates the potentiation of N-methyl-D-aspartate responses in medium spiny striatal neurons 354
Metabotropic glutamate receptors and cell-type-specific vulnerability in the striatum: implication for ischemia and Huntington's disease 354
Totale 39.075
Salva come PNG Salva come JPEG
Categoria #
all - tutte 98.565
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 98.565
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202012.847 0 0 1.267 1.446 1.226 1.678 1.216 1.429 1.285 1.175 981 1.144
2020/20218.340 898 1.132 885 1.102 879 734 1.128 767 207 139 343 126
2021/20221.282 35 71 35 98 16 201 34 51 72 195 38 436
2022/20231.437 190 77 27 138 84 423 157 80 93 4 135 29
2023/2024344 32 13 37 8 32 113 15 27 2 5 0 60
2024/20251.237 83 805 349 0 0 0 0 0 0 0 0 0
Totale 58.119